Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

6.1K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Eighty years of rheumatology-Milestones in diagnosis, treatment and research].

Zeitschrift fur Rheumatologie·2021
Same author

[Treat to target: therapeutic aims/prognosis parameters].

Zeitschrift fur Rheumatologie·2019
Same author

[Tight control-Demand for short term control of rheumatoid arthritis].

Zeitschrift fur Rheumatologie·2019
Same author

[Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population].

Zeitschrift fur Rheumatologie·2018
Same author

[Tips and tricks in court-Practical experience from a medical viewpoint].

Zeitschrift fur Rheumatologie·2018
Same author

[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].

Zeitschrift fur Rheumatologie·2018
Same journal

[Applying the German demand planning guideline to maternity care provision: regional and socioeconomic disparities].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Medical aids for children and adolescents following the legislative change-a status report].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping: caught between fraud, health protection, and responsibility].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Legal and societal aspects of doping in sport].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

50.5K

[Not Available].

S Kary1, G-R Burmester

  • 1Universitätsklinikum Charité, Berlin, Germany.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|April 15, 2014
PubMed
Summary
This summary is machine-generated.

Rheumatoid arthritis treatment has advanced with biological therapies like TNF inhibitors, offering improved efficacy and safety over traditional DMARDs for severe cases. Ongoing research and committees monitor these potent new agents and their long-term effects.

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

24.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

24.4K

Related Experiment Videos

Last Updated: May 1, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

50.5K
Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

24.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

24.4K

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Context:

  • Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease causing joint destruction and extra-articular manifestations.
  • Current treatments lack a definitive cure, necessitating advanced therapeutic strategies.
  • Traditional Disease Modifying Antirheumatic Drugs (DMARDs) have limitations, particularly in refractory RA cases.

Purpose:

  • To review novel biological agents for rheumatoid arthritis treatment.
  • To discuss the efficacy and safety profiles of new cytokine inhibitors.
  • To present current treatment recommendations and cost-benefit analyses for biologicals in RA.

Summary:

  • Biological therapies, including tumor necrosis factor (TNF) α- and interleukin (IL) 1-inhibitors (e.g., infliximab, etanercept, anakinra), demonstrate superior efficacy and safety compared to conventional DMARDs.
  • These advanced agents are particularly beneficial for patients with refractory rheumatoid arthritis.
  • International and national committees are established to oversee the use of these new agents and monitor potential long-term effects.

Impact:

  • Biologicals represent a significant advancement in managing rheumatoid arthritis, offering new hope for patients with severe or refractory disease.
  • The development of targeted cytokine inhibitors provides a more precise approach to controlling RA-associated inflammation.
  • Establishing regulatory frameworks and cost-benefit analyses is crucial for the responsible integration of these potent therapies into clinical practice.